Monday, May 06, 2019 12:55:15 PM
VISALIA, Calif.--(BUSINESS WIRE)--After its recent success in defeating all claims in the lawsuit filed by Aemetis, Inc. (NASDAQ:AMTX), Edeniq, Inc. today announced that it has voluntarily withdrawn its cross-claims. Edeniq had brought this countersuit to assist it in defending against Aemetis’ meritless case; having now achieved that clear victory, Edeniq has chosen not to incur the time and expense of a trial. Edeniq will now turn to recovering the attorneys’ fees and costs it believes it is entitled to pursuant to the parties’ terminated merger agreement.
“By defeating every one of Aemetis’ claims, Edeniq has fully achieved its goals in this litigation. We look forward to putting this lawsuit behind us and continuing to focus on our industry, our investors, and especially our customers”
Tweet this
“By defeating every one of Aemetis’ claims, Edeniq has fully achieved its goals in this litigation. We look forward to putting this lawsuit behind us and continuing to focus on our industry, our investors, and especially our customers,” stated Brian Thome, President and CEO of Edeniq.
About Edeniq, Inc.
Edeniq, Inc. is a leading biotechnology company that develops processes for producing and measuring cellulosic ethanol from corn kernel fiber through its Intellulose technology. Edeniq’s Intellulose requires zero capital investment and is easily integrated into existing ethanol production facilities. Edeniq was established in 2008 and is headquartered in Visalia, Calif. with a field office in Omaha, Neb. More information can be found at www.edeniq.com.
Recent AMTX News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/09/2024 09:27:09 PM
- Aemetis Reports Revenues of $66 Million for the Second Quarter 2024 • GlobeNewswire Inc. • 08/01/2024 01:38:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 12:40:11 PM
- Aemetis to Review Second Quarter 2024 Financial Results on August 1, 2024 • GlobeNewswire Inc. • 07/26/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:02:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:53:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/23/2024 07:49:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:15:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:30:50 PM
- Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- Aemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency Projects • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Aemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion Projects • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Aemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration Projects • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Aemetis Reports 2023 Fourth Quarter and Year-End Results • GlobeNewswire Inc. • 03/07/2024 01:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:25:32 AM
- Aemetis Receives Authority to Construct Air Permits for Riverbank Sustainable Aviation Fuel Plant • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024 • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:45:06 PM
- Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028 • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:46:32 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:19:02 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:54:17 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 11:50:28 AM
- Aemetis Biogas Completes Construction Funding from $25 million USDA Loan for Aemetis Biogas 1 Dairy Digesters • GlobeNewswire Inc. • 02/01/2024 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM